Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists
Cardiovascular disease remains one of the most prominent global health problems and has been demonstrated to disproportionally affect certain communities. Despite an increasing collective effort to improve health inequalities, a multitude of disparities continue to affect cardiovascular outcomes. Am...
| 出版年: | American Journal of Preventive Cardiology |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Elsevier
2023-03-01
|
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2666667723000193 |
